BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6268017)

  • 1. Detection of HBsAg in a clone derived from the PLC/PRF/5 human hepatoma cell line.
    Wen YM; Copeland JA; Mann GF; Howard CR; Zuckerman AJ
    Arch Virol; 1981; 68(3-4):157-63. PubMed ID: 6268017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5).
    Barin F; Goudeau A; Brechot C; Romet-Lemonne J; Sureau C; Lesage G
    Dev Biol Stand; 1983; 54():81-92. PubMed ID: 6317496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B surface antigen produced by a human hepatoma cell line.
    MacNab GM; Alexander JJ; Lecatsas G; Bey EM; Urbanowicz JM
    Br J Cancer; 1976 Nov; 34(5):509-15. PubMed ID: 187208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of receptors for polymerized albumin in HBsAg-containing hepatocytes and hepatoma cell line.
    Thung SN; Gerber MA
    Hepatology; 1981; 1(2):132-6. PubMed ID: 6269978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural analysis of hepatitis B surface antigen production in vitro.
    Aoki N; Thung SN; Gerber MA
    Lab Invest; 1982 Nov; 47(5):465-70. PubMed ID: 6182389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
    Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
    J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced underglycosylation of PLC/PRF/5 human hepatoma cells. Brief report.
    Clementi M; Bagnarelli P; Pauri P; Brugia M
    Arch Virol; 1983; 78(1-2):109-13. PubMed ID: 6316871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human hepatocellular carcinoma: cross-reactive and idiotypic antigens associated with malignant transformation of epithelial cells.
    Wiedmann KH; Trejdosiewicz LK; Southgate J; Thomas HC
    Hepatology; 1987; 7(3):543-50. PubMed ID: 2437001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
    Yamashita Y; Koike K; Takaoki M; Matsuda S
    Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of extracts from Phyllanthus urinaria L. on HBsAg production in PLC/PRF/5 cell line].
    Ji XH; Qin YZ; Wang WY; Zhu JY; Liu XT
    Zhongguo Zhong Yao Za Zhi; 1993 Aug; 18(8):496-8, 511. PubMed ID: 8011099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies by immune electron microscopy of hepatitis B surface antigen in PLC/PRF/5 cells.
    Shibayama T; Watanabe T; Kojima H; Yoshikawa A; Watanabe S; Kamimura T; Suzuki S; Ichida F
    J Med Virol; 1984; 13(3):205-14. PubMed ID: 6327897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human hepatoma-associated cell surface antigen: identification and characterization by means of monoclonal antibodies.
    Shouval D; Eilat D; Carlson RI; Adler R; Livni N; Wands JR
    Hepatology; 1985; 5(3):347-56. PubMed ID: 2987098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of HBsAg produced by the human hepatoma cell line PLC/PRE/5 by affinity chromatography using monoclonal antibodies and application for ELISA diagnostic.
    Merten OW; Reiter S; Scheirer W; Katinger H
    Dev Biol Stand; 1983; 55():121-7. PubMed ID: 6329855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescence detection of liver cell membrane autoantibodies using PLC/PRF/5 cells.
    de Koning RW; Daemen M; Schutte B; Geertzen HG; Blijham GH; Bosman FT
    Eur J Clin Invest; 1985 Apr; 15(2):64-8. PubMed ID: 2986983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma.
    Kiyosawa K; Daemer RJ; He LF; Bonino F; Prozesky OW; Purcell RH
    Hepatology; 1985; 5(4):548-55. PubMed ID: 2991105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of hepatitis B surface antigen in human hepatoma-derived cell lines.
    Oefinger PE; Bronson DL; Dreesman GR
    J Gen Virol; 1981 Mar; 53(Pt 1):105-13. PubMed ID: 6268737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.
    Gerber MA; Garfinkel E; Hirschman SZ; Thung SN; Panagiotatos T
    J Immunol; 1981 Mar; 126(3):1085-9. PubMed ID: 6161957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of hepatitis B surface antigen by the human hepatoma cell line HepG2.
    Kaiser J; Stockert RJ; Schein PS; Wolkoff AW
    Trans Assoc Am Physicians; 1986; 99():86-91. PubMed ID: 3037754
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of insulin on an insulin receptor of PLC/PRF/5 human hepatoma cell line.
    Testa I; Clementi M; Festa A; Bagnarelli P; Brugia M; de Martinis C
    Dev Biol Stand; 1985; 60():81-91. PubMed ID: 2995179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of glucocorticoid hormones on release of HBsAg from PLC/PRF/5 (Alexander) hepatoma cells.
    Marshall J; Coulepis A; Pringle R; Dimitrakakis M; Gust ID
    Acta Virol; 1983 Sep; 27(5):429-33. PubMed ID: 6139947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.